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Abstract 21 
Donor human milk (DHM) is the recommended alternative, if maternal milk is unavailable. However, 22 
current human milk banking practices may negatively affect the nutritional quality of DHM. This 23 
review summarises the effects of these practices on polyunsaturated fatty acids, lipid mediators and 24 
antioxidants of human milk. Overall, there is considerable variation in the reported effects, and 25 
further research is needed, particularly with lipid mediators and antioxidants. However, to preserve 26 
nutritional quality, DHM should be protected from light exposure and storage at 4°C minimised, to 27 
prevent decreases in vitamin C and endocannabinoids and increases in free fatty acids and lipid 28 
peroxidation products. Storage at -20°C prior to pasteurisation should also be minimised, to prevent 29 
free fatty increases and total fat and endocannabinoid decreases. Storage ≤-70°C is preferable 30 
wherever possible, although post-pasteurisation storage at -20°C for three months appears safe for 31 
free fatty acids, lipid peroxidation products, and total fat content. 32 
 33 
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1 Abbreviations:  
2-AG: 2-arachidonoylglycerol 
4-HHE: 4-hydroxy-2-nonenal 
4-HNE: 4-hydroxy-2-hexanal 
AEA: arachidonoyl ethanolamide (anandamide)  
ALA: α-linolenic acid 
ARA: arachidonic acid 
DHA: docosahexaenoic acid  
DHM: donor human milk 
DHEA: docosahexaenoyl ethanolamide 
EPA: eicosapentaenoic acid 
LA: linoleic acid 
LCPUFA: long-chain polyunsaturated fatty acid 
MDA: malondialdehyde 
PUFA: polyunsaturated fatty acid 
SPM: specialised pro-resolving mediator 
TAC: total antioxidant capacity 
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1. INTRODUCTION 38 
Mother’s own breast milk is the accepted best practice for feeding neonates [1] and exclusive breast 39 
feeding for the first six months of life is recommended [2] for term infants. For preterm infants as 40 
well, mother’s own breast milk is the favoured feeding choice. However, it may need to be fortified 41 
to accommodate the preterm infant’s requirements [3]. Producing an inadequate milk supply is 42 
nearly three times more likely in preterm mothers than in term mothers [4]. Underlying reasons can 43 
be physiological, such as incomplete development of the mammary glands, or poor hormonal 44 
response, as well as psychological [5]. In some cases, maternal breast milk might not be appropriate, 45 
due to illness or medication. In these instances, donor human milk (DHM) from a human milk bank is 46 
the best alternative [2, 6, 7]. Although, at least in the U.K., there are no clear guidelines regulating 47 
the use of DHM to a specific preterm gestation, most clinicians agree that extremely preterm infants 48 
(born at less than 28 weeks gestational age) should receive DHM [8]. Similarly the Human Milk 49 
Banking Association of North America recommends the use of DHM for preterm infants or infants 50 
with a birth weight of less than 1750 g [9]. The American Academy of Pediatrics recommends use of 51 
DHM for all preterm infants, especially those weighing <1500 g, when mother’s own milk is not 52 
available or sufficient [10]. 53 
Breast milk is generally the only food infants receive for the first few months of life. It provides 54 
macro- and micronutrients, immunological factors, hormones, enzymes, growths factors, essential 55 
fatty acids and other biologically active compounds, essential for the infant’s development [11]. 56 
Adequate dietary nutrient supply is especially important for preterm infants since their maternal 57 
nutrient supply has been interrupted prematurely. For example, during the last trimester, the brain 58 
weight increases approximately five-times and at the same time around 80% of the brain 59 
docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) are accumulated [12]. 60 
Preterm birth also deprives the infant of enzymatic and non-enzymatic antioxidants that would have 61 
been matured or gained through maternal transfer in the third trimester, respectively [13, 14]. 62 
DHM undergoes prolonged cold storage, freeze-thaw cycles, and processing, before it is fed to 63 
infants, which may negatively affect the breast milk composition. For example, in the U.K., expressed 64 
breast milk for donation can be stored for up to 24 hours at 4°C, before transferring to a -18°C (or 65 
below) freezer for up to three months [15]. Breast milk is then thawed, Holder pasteurised (62.5°C, 66 
30 minutes) and refrozen for up to three months. Before feeding, thawed pasteurised DHM can be 67 
stored at 4°C for up to 24 hours. These conditions have been summarised in Figure 1. Similar 68 
guidelines are followed widely, including in Australia, North America, Sweden, Italy, Spain, and India 69 
[16-21]. Additionally, in Italy, breast milk undergoing direct pasteurisation after expression, can be 70 
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stored for up to 72 hours at 4°C [18]. In Sweden, fresh and pasteurised DHM can be stored for 71 
48 hours at 4°C and can be kept for a maximum of two hours at room temperature [19]. Lack of 72 
evidence is one reason for the different practices used for some aspects of human milk banking [22].  73 
 74 
 75 
Figure 1: Donor human milk storage and processing conditions 76 
Donor human milk (DHM) is exposed to various storage conditions at donors’ homes, the human milk 77 
bank, and the neonatal unit. This figure displays the storage conditions allowable under the U.K. 78 
National Institute of Health and Care Excellence (NICE) guidelines [15]. Similar processes are used 79 
worldwide. 80 
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Recommendations for human breast milk storage conditions were predominantly developed to 81 
minimise bacterial growth, rather than to preserve nutritional components [23, 24]. However, with 82 
the increasing demand for DHM, and improvements in neonatal care leading to even younger infants 83 
surviving, it is now imperative that the nutritional quality of DHM is prioritised. Therefore, this article 84 
reviews the effects of current storage and processing conditions on long-chain polyunsaturated fatty 85 
acid (LCPUFA) content, bioactive lipid mediators, and antioxidants in human breast milk. Gao and 86 
colleagues recently published a systematic review on the effects of storage, handling and processing 87 
on breast milk fatty acid composition [25]. This present article compliments and extends these 88 
observations by also reviewing lipid peroxidation, bioactive lipid mediators and endogenous 89 
antioxidants. The effects of Holder pasteurisation on nutrients have been described elsewhere [26], 90 
and are not part of this review.  91 
 92 
2. SEARCH METHODOLOGY 93 
A search and discovery tool was used to search 80 databases, including Scopus, Web of Science, 94 
Medline, and Cinahl, using the following search terms: ((human milk) OR (donor milk) OR (donor 95 
human milk) OR (breast milk)) AND ((thaw* OR freeze* OR storage OR processing OR (cold storage) 96 
OR (-20 degree C) OR (-80 degree C) OR refrigeration) OR stability) AND ((fat OR lipid* OR 97 
triacylglycerol* OR triglyceride* OR (fatty acid) OR (long chain polyunsaturated fatty acid*) OR 98 
(polyunsaturated fatty acid*) OR (docosahexaenoic acid) OR (arachidonic acid) OR (free fatty acid*) 99 
OR lipolysis OR macronutrient* OR eicosanoid* OR leukotriene OR prostaglandin OR thromboxane 100 
OR (specialized pro resolving mediator*) OR (specialized pro-resolving mediator*) OR lipoxin* OR 101 
resolvin* OR protectin* OR maresin* OR endocannabinoid* OR (arachidonoyl ethanolamide) OR 102 
(docosahexaenoyl ethanolamide) OR arachidonylglycerol OR (lipid peroxidation) OR hexanal OR 103 
alkenal OR (lipid hydroperoxide*) OR malonyldialdehyde OR TBARS OR MDA OR hydroxynonenal OR 104 
hydroxyhexenal OR antioxidant* OR (vitamin C OR ascorbic acid) OR (vitamin E) OR tocopherol* OR 105 
(superoxide dismutase) OR catalase OR glutathione OR (glutathione peroxidase) OR (total 106 
antioxidant capacity)) OR (antioxidant capacity) OR (antioxidant status)). Furthermore, ‘snowballing’, 107 
searching the reference lists of the identified literature, was used [27], as well as searching google 108 
scholar. Studies were included when full text was available, the language of the publication was 109 
English and the publication date was before April 2019. Studies describing solely the effect of 110 
pasteurisation on nutrients were excluded.  111 
 112 
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3. TOTAL FAT CONTENT AND LONG-CHAIN POLYUNSATURATED FATTY ACIDS 113 
Breast milk contains DHA and ARA, LCPUFAs of the omega-3 and omega-6 series, respectively [28]. 114 
DHA levels in breast milk are highly variable, ranging from 0.17% to 0.99% of total fatty acids, 115 
whereas ARA levels are more constant (0.36% to 0.49% of total fatty acids) [29]. Intrauterine 116 
accretion rates for DHA and ARA peak in the last trimester [30], a time when DHA is also selectively 117 
favoured for placental transport to the foetal circulation [31]. This leads to a bio-magnification of 118 
LCPUFAs in the foetus, providing it with substrates for the developing brain [32]. In preterm infants, 119 
maternal supply has been interrupted prematurely, and they therefore have an elevated 120 
requirement for enteral LCPUFA intake. Indeed, preterm infants have significantly lower DHA and 121 
ARA blood levels than term infants [33]. Term infants fed with formula milk devoid of DHA will 122 
rapidly exhaust their adipose tissue DHA stores [34]. This is also reflected by significant decreased 123 
erythrocyte DHA levels at day five of feeding formula milk devoid of DHA to term infants [35]. 124 
Importantly, erythrocyte DHA status has been correlated with brain DHA status [36]. Preterm infants 125 
have in contrast to term infants very low adipose tissue stores [30, 37], which makes them even 126 
more dependent on adequate enteral LCPUFA intake. Inefficient conversion rates from precursor 127 
fatty acids [38, 39], as well as an enteral LCPUFA absorption rate of only 80% [40], and the prolonged 128 
period it may take until full enteral feeding is achieved, further limit the LCPUFA availability for 129 
preterm infants. However, it is critical to provide preterm babies with sufficient amounts of LCPUFAs 130 
optimal for brain and visual development, as well as cell and immune system function [41, 42]. 131 
Although preterm breast milk may contain higher DHA levels than term breast milk, [43], we have 132 
previously shown that extremely preterm infants under standard care receive very low levels of DHA 133 
and ARA, which are reflected in low blood fatty acid levels [44]. Importantly, DHM is provided 134 
generally by mothers of term infants and consequently lower in LCPUFA levels [45]. It is therefore 135 
imperative that all appropriate steps are taken to maintain LCPUFA levels on the journey from donor 136 
to recipient. Since the total fat and LCPUFA content of DHM may be sensitive to human milk banking 137 
practices, the following section provides an overview of the literature investigating the effects of 138 
different storage conditions on human breast milk lipids, and is summarised in Table 1.  139 
Storing breast milk at 4C for 48 hours has been shown to not significantly change the absolute or 140 
relative fatty acid content [46], or triacylglycerol content [47]. The latter was also not affected by 141 
refrigeration at 4C for up to three days [48]. Total lipid content was also unchanged by refrigeration 142 
at 4C for 24 hours [49], or up to 96 hours [50]. Similarly, polyunsaturated fatty acid (PUFA) content 143 
(including linoleic acid (LA, 18:2n-6), α-linolenic acid (ALA, 18:3n-3), ARA and DHA), as well as 144 
saturated and monounsaturated fatty acid content was not significantly altered when stored for 145 
96 hours at 4°C [23] or 6.8°C [51].  146 
7 
 
Several studies show that total fat content is not significantly altered following storage at -20°C for 147 
nine months [52], nor does absolute fatty acid and relative fatty acid content change significantly in 148 
studies ranging from storage for 30 days [46] to 12 months [23]. Furthermore, storage at -20°C for 149 
3 days, or -18°C for 28 days does not change total triacylglycerols levels [47, 48]. Total fat and 150 
relative fatty acid levels were unaffected by storage at -25°C for three months, although these 151 
samples were refrigerated for up to 48 hours before baseline analysis [53]. Consistent with these 152 
observations, storing breast milk for one week at -4 to -8°C did not change the fat content [49]. 153 
However, others have found that storage at -20°C significantly decreases total fat after 48 hours 154 
[54], 30 days [55, 56], and up to 24 weeks [57]. Similarly, total lipid concentrations [58], and 155 
triacylglycerols [59], significant decrease after eight days, and five months, at -20°C respectively. 156 
Significant reductions in fat content after storage at -20°C were also seen after seven days and up to 157 
90 days, with the biggest decreases in the first week (-0.027 g/dL/day) [60]. Freezing at -80°C for five 158 
months did not affect saturated or monounsaturated fatty acids, or PUFAs [23], or triacylglycerols 159 
for 12 months [59]. Although -80°C storage was shown to result in a significant decrease of fat, this 160 
was lower than the decreases seen at -20°C [57]. In contrast, significant decreases in fat content of 161 
91% were seen after 44 days of breast milk storage at -80°C, which led to the conclusion of the 162 
authors that storage at -80°C should not be the gold standard as recommended by other researchers 163 
[61]. This result is unexpected and since no comparison was undertaken with storage at -20°C, the 164 
results should be considered within the context of the wider literature. Discordant observations 165 
have also been seen post-pasteurisation, with storage at -20°C for 90 and 180 days resulting in 5.7% 166 
and 2.9% decreases in total fat content, respectively [62, 63], whereas, no differences in total fat 167 
content [64, 65], or relative fatty acid concentrations [64] of pasteurised breast milk stored for 168 
1 month at -25°C or up to 12 months at -20°C, respectively were seen.  169 
During human milk banking breast milk is thawed and then refrozen, which has the potential to 170 
affect the milk fat quality. Three-times freezing and thawing has been shown to lead to reductions in 171 
fresh breast milk triacylglycerols of up to 5% [59]. Freezing and thawing breast milk for three-cycles 172 
before storing it at -20 °C for five months resulted in an additional 3% triacylglycerol loss (13% in 173 
total, compared to 10% after freezing only). Relative amounts of saturated, and monounsaturated 174 
fatty acids of breast milk triacylglycerols did not change significantly after two freeze thaw cycles, 175 
whereas the relative LA content decreased by -65% [66]. It is noteworthy that thawing in the fridge 176 
(4°C) for 24 hours, as recommended in the U.K. [15], significantly reduced total fat loss compared to 177 
thawing in a water-bath (37°C, 30 minutes) [55]. Vieira and colleagues found no significant 178 
difference in total fat content when pasteurised breast milk was thawed in a water-bath (40°C, 179 
10 minutes) or thawed in a microwave (45 seconds) [67]. No difference in fat content was found 180 
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when thawing under tepid water and thawing by a waterless dry heat warmer were compared [68]. 181 
Chang and colleagues also found that storage (-20°C, 48 hours) in light brown coloured 182 
polyethersulfone bottles resulted in the least fat decreases [54].  183 
In conclusion, the available evidence suggests that storage at 4°C is sufficient to minimise decreases 184 
in total fat and LCPUFAs in breast milk for up to 96 hours. However, for longer-term storage the data 185 
for storage at -20°C is highly discordant, especially pre-pasteurisation. These differences may be 186 
related to variations in analytical methods used [69, 70], or methodological variations, such as not 187 
sufficiently homogenising the breast milk after storage [71], differences in fat adherences to the 188 
container walls [54, 61], particularly to polyethylene [72], and variations in fat loss due to different 189 
thawing methods [55], which are not specifically defined in the literature. Furthermore, breast milk 190 
is a complex biological matrix, and variations in unmeasured endogenous antioxidant levels or other 191 
components, may influence fat content stability during storage, discussed further in Section 7 below. 192 
However, overall the evidence suggests storage at -80°C is the best option for longer-term storage to 193 
maintain total fat and CLPUFA levels.  194 
9 
 
Table 1: Summary of studies investigating the effects of storage conditions on total fat and LCPUFA content  195 
 Breast milk samples, storage temperature and duration Study outcome 
[46] Fresh 
4°C for 48 hours, or -20°C for 30 days 
No significant differences in absolute or relative fatty acid content between fresh, 
refrigerated, or frozen breast milk 
[47] Fresh 
4°C for 48 hours, or -18°C for 28 days 
No significant differences in triacylglycerol content between fresh, refrigerated, or 
frozen breast milk 
[48] Fresh 
4°C for 72 hours, or -20°C for 72 hours 
No significant differences in triacylglycerol content between fresh, refrigerated or 
frozen breast milk 
[49] Fresh 
4-6°C for 24 hours, or -4 to -8°C for 1 week 
No significant differences in fat content between fresh, refrigerated or frozen 
breast milk 
[50] Fresh 
4°C for 24, 48, 96 hours 
All samples were stored at -80°C until analysis 
No significant differences in total lipid content between fresh, or refrigerated 
breast milk  
[23] Fresh 
4°C for 3, 6, 9, 12, 24, 48, 72, 96 hours 
-20°C or -80°C for 3, 5, 8, 12 months 
No significant differences in relative LA, ALA, ARA, DHA, saturated, 
monounsaturated, or polyunsaturated fatty acid content between the different 
storage times and temperatures 
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[51] Fresh (within 3 hours of collection) 
6.8°C for 24, 48, 72, 96 hours 
No significant differences in absolute saturated or monounsaturated fatty acids, 
PUFAs, LCPUFAs, or the saturated to unsaturated fatty acid ratio between fresh 
and refrigerated breast milk at any storage time 
[52] Fresh 
4°C for 72 hours and then stored at -20°C for 1, 3, 6, 9 months 
All samples stored at -80°C after the initial storage time until 
analysis 
No significant differences in total fat content between fresh, refrigerated and 
frozen, or directly frozen breast milk at the different storage conditions 
[53] Fresh (up to 48 hours at 4°C )  
-25°C for 1 week, 1, or 3 months  
No significant differences in total lipid or relative fatty acid concentration between 
fresh or frozen breast milk  
[54] Samples stored in 9 different commercial milk containers for 
maximum 3 days at 4°C, before transfer to -20°C for 2 days 
No significant differences in total fat content of breast milk stored in different 
containers 
Least fat loss in light brown coloured polyethersulfone bottles 
Significant total fat decrease in breast milk after freezing, storing and thawing 
(-0.27 to -0.30 g/dL, p = 0.02) 
[55] Fresh 
-20°C for 30 days, then thawed at 4°C for 24 h, or at 37°C for 30 
Total lipids (g/100 mL): Fresh: 2.98 vs thawing at 4°C: 2.76 vs thawing at 37°C: 2.66  
Significant less mean fat loss in frozen breast milk thawed at 4°C compared to 
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minutes thawing at 37°C (p = 0.02) 
[56] Fresh  
-20°C for 30 days 
Significant fat decrease after frozen storage  
Fat (g/100 mL): Fresh: 2.98 vs 30 days frozen: 2.66 (p < 0.001) 
[57] Fresh (up to 24 hours at 4°C) 
-20°C or -80°C for 4, 12, 24 weeks 
Fat content was consistently higher in breast milk stored at -80°C than at -20°C 
(p < 0.0005) 
Difference in fat content between 4 and 24 weeks was 0.3 g/100 mL at -20°C 
(p = 0.001) and 0.14 g/100 mL at -80°C (p = 0.009) 
[58] Fresh 
-20°C for 4, 8 days  
Significant total lipid decrease in breast milk stored at -20°C 
Lipids (g/100 mL): Group 1 (no bacterial growth): fresh: 3.92 vs frozen for 4 days: 
3.61 vs frozen for 8 days: 3.54, no significant differences 
Group 2 (containing saprophytes): fresh: 3.84 vs frozen for 4 days: 3.8 vs frozen for 
8 days: 3.61 (p = 0.003) 
Group 3 (containing potential pathogens): fresh: 4.75 vs frozen for 4 days: 4.76 vs 
frozen for 8 days: 4.65, (p = 0.002) 
[59] Fresh (up to 3 hours before analysis) 
Analysed directly after 1, 2, or 3 freeze-thaw cycles (dry ice and 
Maximum 5% decrease in triacylglycerols after freeze-thawing of fresh breast milk 
Breast milk storage at -20 °C resulted in a 10% decrease of triacylglycerols, or a 
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acetone-cold water for thawing)  
Storage at -20°C or -70°C for 5 months after 0, 1, 2, or 3 freeze-
thaw cycles 
13% decrease after 3 freeze-thaw cycles 
Storage at -70°C resulted in no significant changes 
[60] Fresh 
-20°C for 7, 15, 30, 60, 90 days 
Significant total fat reduction in breast milk at each day after storage 
Fat (g/dL): Fresh: 4.88 vs 7 days frozen: 4.69 (p = 0.002) vs 15 days frozen: 4.54 
(p = 0.001) vs 30 days frozen: 4.54 (p < 0.001) vs 60 days frozen: 4.37 (p < 0.001) vs 
90 days frozen: 4.19 (p < 0.001) 
 
[62] Fresh (4°C during same day transport to the laboratory) 
Pasteurised, then stored at -20°C for 35, 70, 90 days 
Post-pasteurisation frozen storage for 90 days decreased total fat concentration by 
5.7%, which was above the relative standard deviation of fresh breast milk 
 
[63] Storage in donors’ freezers until transfer to the hospital 
Storage at -20°C at the hospital 
Thawing, heating to 40°C and homogenisation, Holder 
pasteurisation, heating to 40°C and homogenisation 
Analysis day 0 (post-pasteurisation) 
Significant total fat decrease over time (p = 0.001) in frozen breast milk  
Mean difference between 0 and 180 days was -0.13 g/dL  
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Storage at -20°C for 30, 60, 90, 120, 150, 180 days 
[64] Fresh (up to 48 hours at 4°C )  
Holder pasteurised, then stored at -25°C for 1 month 
No significant differences in total lipid or relative fatty acid concentration between 
fresh or pasteurised and frozen breast milk 
[65] Pasteurised, then stored at -20°C for 1, 2, 3, 4, 5, 6, 8, 10, 12 
months 
No significant differences in total fat between any of the storage times 
[61] Fresh (up to 24 hours at 4°C) 
-80°C for mean of 43.8 days (range 8-83 days) 
Significant decrease of total fat concentration after frozen storage 
Total fat (g/100 mL): Fresh: 37.2 vs frozen: 3.36 (p < 0.001) 
[66] Fresh (up to 3 hours at 18-20°C)  
Frozen at -20°C, thawed at room temperature once, twice or 
three times  
Freezing and thawing resulted in a loss of absolute milk triacylglycerols 
Relative amounts of saturated and monounsaturated fatty acids of breast milk 
triacylglycerols did not change significantly after two freeze-thaw cycles 
Relative LA concentration (%) changed significantly: Control: 6.64 vs freeze thaw 1: 
4.71 vs freeze thaw 2: 2.35 (p < 0.01) vs freeze thaw 3: 2.60 (p < 0.002)  
ALA could not be measured accurately 
[67] Frozen at -20°C, thawed in a water-bath (40°C, 10 minutes) or in 
a microwave (45 seconds) 
No significant difference in fat content between the two thawing methods 
[68] Frozen at -20°C, thawed under tepid water or by waterless dry No significant differences in fat content between the two thawing methods 
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heat warmer 
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4. FREE FATTY ACID LEVELS 196 
The lipid portion of breast milk consists of approximately 98% triacylglycerols, 1% phospholipids, and 197 
0.4% cholesterol and cholesterol esters [73]. Breast milk also contains the bile salt-dependent lipase, 198 
which aids in the digestion of milk fat and compensates for the immature digestive system in new-199 
borns [74, 75]. However, the bile salt-dependent lipase loses its bile salt specificity during two weeks 200 
frozen storage at -10°C [76], potentially resulting in lipolysis of triacylglycerols and an increase in 201 
free fatty acid levels. Freezing and thawing also damages the fat globule membrane, allowing the 202 
lipases greater access to triacylglycerols, thereby increasing free fatty acid levels [59, 77]. LCPUFAs 203 
appear more susceptible to hydrolysis than shorter-chain fatty acids and the degree of hydrolysis is 204 
temperature and time dependent [78]. Additionally, elevated levels of free fatty acids have the 205 
potential to increase lipid peroxidation [79, 80], discussed in Section 6.  206 
Storing breast milk at 4°C increases the free fatty acid content significantly from 51% to 454% after 207 
24 hours [51, 78, 81], from 76% to 502% after 48 hours [51, 78], from 85% to 101% after 72 hours 208 
[82] and by 265% after 96 hours [50], although breast milk samples in the latter study were stored 209 
at -80°C after refrigeration, until subsequent free fatty acid analysis [50]. In a time course 210 
experiment, higher free fatty acid levels were seen at 48 hours compared to 24 hours, although not 211 
statistically significant, whereas levels were significantly higher at 72 hours, with the greatest 212 
increases seen with omega-3 PUFAs [51]. However, pasteurised, frozen, and thawed DHM samples 213 
stored at 4°C for up to 96 hours show no change in free fatty acid levels following thawing [50]. 214 
Free fatty acids in breast milk increased significantly (+589% vs baseline) after eight weeks storage 215 
at -11°C [78], also, an accumulation of free fatty acids has been seen after 24 hours at -20°C, 216 
increasing by 167% after 30 days, and 833% after 180 days [83]. This is supported by other studies 217 
showing significant increases in free fatty acids after storage at -20°C for two to five months [84], 218 
four months [77], five months [59], and nine months [52]. No free fatty acids were detected after 219 
breast milk storage at -80°C for four months [77]. Storage for two months [78], two to five months 220 
[84], or five months [59] at -70°C did also not increase free fatty acid concentrations significantly. 221 
Storage of Holder pasteurised breast milk for one month at -25°C [64], or for three months at -20°C 222 
[62] did not significantly alter the free fatty acid content, and heating for 1.5 minutes at 80°C 223 
prevented the formation of free fatty acids in breast milk samples stored for four months at -20°C 224 
[77].  225 
Thoroughly thawing DHM and keeping it in the fridge for a maximum of 24 hours is recommended 226 
by the U.K. guidelines [15]; however, thawing breast milk at 4°C for 24 hours resulted in 10% and 227 
29% higher free fatty acid concentrations than thawing at room temperature for 2.5 to 4.25 hours, 228 
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or thawing in a water-bath (50°C, 12 to 30 minutes), respectively [85]. A significant increase in free 229 
fatty acids was found after thawing (tepid water or waterless dry heater) breast milk [68]. 230 
Furthermore, refrigeration of thawed breast milk for up to 24 hours before warming and feeding 231 
further increased free fatty acids compared to only warming. Thawing and storing breast milk for 232 
24 hours at 4°C, after 30 days storage at -20°C, further increased the free fatty acid concentration by 233 
approximately 288%, compared to storage at -20°C for 30 days alone [83].  234 
Overall, the evidence strongly suggests that storing breast milk at 4°C prior to pasteurisation 235 
significantly increases the free fatty acid levels, although these changes are not observed post-236 
pasteurisation. These differences are potentially due to inactivation of the breast milk lipases [86]. 237 
Similarly, pre-pasteurisation storage at -20°C has been shown to increases free fatty acid levels, 238 
which are also not seen in post-pasteurisation breast milk. Therefore, in order to minimise increases 239 
in free fatty acids levels, it is recommended expressed breast milk should be frozen immediately and 240 
stored at the lowest possible temperature (ideally -70°C or below) prior to pasteurisation.  241 
 242 
5. LIPID MEDIATORS 243 
5.1 Eicosanoids 244 
Eicosanoids include the eicosapentaenoic acid (EPA, 20:5n-3) and ARA-derived thromboxanes, 245 
prostaglandins and leukotrienes, which are important mediators of the inflammatory response [87]. 246 
Prostaglandins also modulate gastrointestinal function and may protect against gastrointestinal 247 
injuries [88]. Eicosanoids (leukotriene E4, prostaglandin E2, cysteinyl leukotrienes, prostaglandins E 248 
and F, as well as the inactive thromboxane A2, prostacyclin, and prostaglandin F metabolites 249 
thromboxane B2, 6-keto-prostaglandin F1α, and 13,14-dihydro-15-ketoprostaglandin) are secreted 250 
into breast milk [89-91]. To the authors’ knowledge, there have to date been no published studies 251 
looking at the effects of storage conditions or DHM processing on eicosanoid levels in breast milk. 252 
However, Lucas and Mitchel hypothesize that a low 13,14-dihydro-15-253 
ketoprostaglandin F:prostaglandin F ratio in breast milk suggests that prostaglandins are not rapidly 254 
metabolised in breast milk and may persist long enough to have an effect in the infant [89], and 255 
tritiated prostaglandins show minimal degradation after incubation in breast milk for 30 minutes at 256 
37°C [92], suggesting that further work should seek to explore this area. 257 
  258 
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5.2 Specialised pro-resolving mediators 259 
Specialised pro-resolving mediators (SPMs) facilitate the resolution of inflammation, are anti-260 
inflammatory, reduce pain, and facilitate wound healing [93, 94]. They include the ARA-derived 261 
lipoxins, EPA-derived resolvins, and docosapentaenoic acid (22:5n-3) and DHA-derived resolvins, 262 
(neuro)protectins and maresins [95]. Breast milk contains the SPMs resolvin D1, resolvin D2, resolvin 263 
D3, resolving D4, resolvin D5, resolvin D6, protectin 1, maresin 1, resolvin E2, resolvion E3, lipoxin A4 264 
and lipoxin B4 in biologically relevant concentrations, which have shown to reduce the maximum 265 
neutrophil number and to shorten the resolution interval in vivo and to stimulate efferocytosis in 266 
vitro [96]. Resolution of inflammation is especially important for extremely preterm infants, in which 267 
sustained elevated inflammation in the first month of life is associated with cognitive impairment at 268 
ten years of age [97]. To the authors’ knowledge, there are currently no studies that have 269 
investigated the effects of storage conditions on specialised pro-resolving mediator levels in breast 270 
milk. Interestingly, the breast milk samples in the above study [96] were obtained from a commercial 271 
supplier, who stores breast milk at -20°C , and therefore, it is likely that specialised pro-resolving 272 
mediators tolerate some frozen storage; however further work should seek to extend these 273 
observations and investigate the effects of different storage and processing conditions on SPM 274 
levels. 275 
 276 
5.3 Endocannabinoids 277 
Endocannabinoids include the ARA derived compounds arachidonoyl ethanolamide (anandamide, 278 
AEA), 2-arachidonoylglycerol (2-AG), and the DHA-derived docosahexaenoyl ethanolamide (DHEA) 279 
[87], which have been identified in breast milk [98, 99]. The endocannabinoid system plays an 280 
important role in neuronal development and neuroprotection early in life [100, 101]. Animal studies 281 
showed that 2-AG and activation of the Cannabinoid Receptor 1 plays a critical role in milk suckling, 282 
holding on to the nipple, and therefore, growth and survival in the first week of life [98, 100]. An 283 
analysis of breast milk found a non-significant increase of 503% in 2-AG levels after storage at 4°C for 284 
24 hours and a significant increase (1166%) after storage at -20°C for three months [99]. Storage at -285 
80°C for three months did not affect AEA and 2-AG concentrations. DHEA was no longer detectable 286 
after storage at 4°C for one day, or storage at -20°C or -80°C for three months. The authors 287 
suggested that the concentrations of 12 endocannabinoid related compounds (2-AG, AEA, 288 
oleoylethanolamide, palmitoylethanolamide, N-arachidonoyl glycine, eicosapentaenoyl 289 
ethanoalmide, DHEA, N-palmitoleoyl-ethanolamine, dihomo-γ-linolenoylethanolamine, 290 
N-stearoylethanolamine, prostaglandin F2α ethanolamide, prostaglandin E2 ethanolamide) in breast 291 
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milk are stable for a maximum of 24 hours at 4°C, maximum one week at -20°C and that longer term 292 
storage requires temperatures of -80°C. The same group also demonstrated that two freeze-thaw 293 
cycles, as used in human milk banking, resulted in losses of 37% AEA, 49% 2-AG, and 36% DHEA in 294 
bovine milk [102]. Additionally, it has been shown that 2-AG in culture medium and biological 295 
buffers adheres to glass and plastic surfaces [103], which could impact on their availability for the 296 
infant.  297 
 298 
6. LIPID PEROXIDATION PRODUCTS 299 
Omega-3 and omega-6 LCPUFAs are highly susceptible to peroxidation by oxygen radicals [104]. 300 
There is a linear dependency between the number of double bonds and the oxidisability of PUFAs 301 
[105]. Lipid hydroperoxides are unstable primary lipid peroxidation products, which react further to 302 
form secondary lipid peroxidation products [106]. For example, malondialdehyde (MDA) is produced 303 
from the unspecific peroxidation of PUFAs with more than two double bonds. At high levels, lipid 304 
peroxidation products can bind to DNA and proteins, which can lead to cell and tissue damage, and 305 
may thereby increase inflammation [107]. Repeated intake of lipid peroxidation products has been 306 
shown to induce growth retardation, intestinal irritation, cardiovascular diseases, and to be 307 
carcinogenic in animal studies [108]. Direct activation of inflammatory pathways such as nuclear 308 
factor  B has also been shown after feeding lipid peroxidation products to mice [109]. More 309 
importantly, lipid peroxidation products do not only act locally in the intestine, but can also be 310 
absorbed and act elsewhere in the body [109]. 311 
Various lipid peroxidation products have been detected in breast milk, including MDA [79, 110], the 312 
omega-6 and omega-3 PUFA derived 4-hydroxy-2-hexanal (4-HNE) and 4-hydroxy-2-nonenal (4-HHE), 313 
respectively [111], lipid hydroperoxides [80, 112], isoprostanes [113], alkanals including pentanal, 314 
hexanal, octanal, nonanal, and 2-octanal [114], as well as conjugated dienes [80]. Storage of fresh 315 
breast milk for 24 hours at room temperature significantly increases the 4-HNE:omega-6 fatty acid 316 
ratio [111]. Storage at 4°C for 48 hours was shown to significantly increase MDA content of breast 317 
milk [110], whereas others found storage at 4C for 96 hours has no effect on MDA content of 318 
preterm milk [51] potentially due to higher antioxidant capacity in the latter [115]. Although 319 
thiobarbituric acid reactive substances increased by 66% and conjugated dienes by 31% in the same 320 
samples, this was not statistically significant [51]. Storage at 4°C for four days increases LA 321 
hydroperoxides significantly [112].  322 
No significant increases in breast milk MDA levels were seen after storage at -20°C for ten days 323 
[110], or 15 or 30 days, although increases were found after 60 days [116]. Similarly, no increases in 324 
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thiobarbituric acid reactive substances or conjugated dienes were seen after storage at -20°C for two 325 
months, although significant increases in precursor lipid hydroperoxides were found [80]. However, 326 
it should be noted that the fresh breast milk samples were from different donors than the frozen 327 
samples. MDA levels also significantly increased in term breast milk stored at -80°C for 60 days [116]. 328 
Hexanal levels significantly increased after three months storage at -18°C, with further increases 329 
after five and six months [117]. In this study, four months storage of breast milk in amber glass 330 
bottles also reduced the hexanal increase significantly compared clear glass bottles or low density 331 
polyethylene bags. Overall, the literature suggests an increase in lipid peroxidation when breast milk 332 
is stored at 4°C, with short-term storage at -20°C for maximal one month preferable, although there 333 
needs to be more research to clarify this, as well as whether storage at -80°C would be beneficial.  334 
 335 
7. ANTIOXIDANTS 336 
Preterm infants have immature antioxidant systems and inadequate antioxidant capacity [118] and 337 
there is a frequent requirement for blood transfusions, which increases oxidative stress [119]. 338 
Furthermore, the foetal to neonatal transition rapidly increases tissue oxygenation, thereby abruptly 339 
increasing the generation of reactive oxygen species [120], and oxygen therapy as well as total 340 
parenteral nutrition expose the premature infant to further sources of oxidative stress [121]. As a 341 
consequence, there is great potential for peroxidation of endogenous lipids and subsequent tissue 342 
damage. Bronchopulmonary dysplasia, retinopathy of prematurity, necrotising enterocolitis and 343 
peri-ventricular leukomalacia are common comorbidities in preterm infants, which are classified as 344 
oxygen radical associated diseases [122]. Moreover, extremely and very preterm infants are not 345 
routinely supplemented with dietary antioxidants, as there has been limited research in this area 346 
and the outcomes of some trials have been equivocal [123]. Therefore, breast milk, which includes 347 
enzymatic (e.g. superoxide dismutase, glutathione peroxidase) and non-enzymatic (e.g. vitamin C, 348 
vitamin E, glutathione) antioxidants, is the only enteral source of antioxidants for preterm infants. 349 
However, DHM, compared to breast milk, has significantly lower concentrations of several 350 
antioxidants [124].  351 
Antioxidants are not only beneficial to the infant directly, but they also serve to protect PUFAs in the 352 
breast milk from lipid peroxidation and may subsequently decrease  the levels of potentially toxic 353 
compounds [125]. For example, vitamin C can directly prevent lipid peroxidation by scavenging free 354 
radicals, and thereby preventing the initiation stage of lipid peroxidation [126], and vitamin E can 355 
scavenge lipid peroxyl radicals and is then regenerated by vitamin C [127], which in turn is 356 
regenerated by glutathione [128]. Glutathione and the glutathione peroxidase can form more stable 357 
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lipid alcohols from lipid hydroperoxides [129], and glutathione is also involved in the detoxification 358 
of MDA [130]. Although evidence for the prevention of lipid peroxidation in human milk by 359 
antioxidants is limited, evidence suggests that the vitamin E content of formula milk is inversely 360 
related to thiobarbituric acid reactive substances and conjugated dienes [80, 131], and lower 361 
glutathione peroxidase activity is associated with higher MDA concentrations in breast milk following 362 
refrigeration [110]. Due to the interplay and synergistic effects between antioxidants, antioxidant 363 
capacity should also be considered an appropriate measure of the antioxidant status of breast milk.  364 
 365 
7.1 Vitamin C 366 
Term breast milk contains around 34.7 ± 1.33 mg/L vitamin C (ascorbic acid + dehydroascorbic acid) 367 
[23]. Significant reductions in the vitamin C content of term breast milk have been reported after 368 
storage at 4°C for six hours, and 24 hours [24, 49, 132-134], and after one week at -4 to -8°C [49], as 369 
well as after two months at -16°C [24]. Interestingly, significant decreases in vitamin C were seen 370 
after three months storage at -20°C in term, but not preterm breast milk [134], although, in another 371 
study significant decreases were seen in preterm breast milk after seven and 30 day storage at the 372 
same temperature [135]. However, others have reported that vitamin C levels are stable at -20°C in 373 
pooled breast milk for four week [136], and up to three months, but significantly decrease after 374 
eight months [23]. Vitamin C content appears stable with storage at -80°C for eight months, 375 
although a significant decrease of 12% was seen at 12 months [23]. Overall, although the results are 376 
somewhat mixed, the evidence supports breast milk storage at lower temperatures to protect 377 
Vitamin C content, with storage at both 4°C and -20°C leading to decreases, and storage at -80°C 378 
preferable, for the maximum recommended storage time of six months, although this is based on 379 
one publication. 380 
 381 
7.2 Vitamin E  382 
Vitamin E is a class of compounds including α-, β-, γ- and δ-tocopherol, with α-tocopherol being the 383 
main isomer in term mature breast milk, and one of the main contributors to antioxidant capacity of 384 
breast milk, which is found at concentrations of 2.32 ± 0.11 mg/L [137]. Storage of breast milk at 4°C 385 
for 24 hours did not affect α- and γ-tocopherol levels in several studies [23, 49, 138], likewise, no 386 
significant changes were found after 48 hours for α-, β-, γ-, and δ-tocopherol [46], although others 387 
have reported significant reductions in α- and γ-tocopherol levels after 48 hours [23]. Storing breast 388 
milk at -4 to -8°C for one week resulted in a significant decrease in vitamin E [49]. Storage at -20°C 389 
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did not affect vitamin E levels of breast milk stored for 30 days [46], 16 weeks [138], six months 390 
[139], or 12 months [23], and no changes in vitamin E levels were seen after storage for 16 weeks 391 
[138], or six months at -70°C [139], or 12 months at -80°C [23]. Overall, the evidence suggests that 392 
current human milk banking storage processes are safe to protect the vitamin E content in DHM. 393 
 394 
7.3 Superoxide dismutase, glutathione, and glutathione peroxidase 395 
Superoxide dismutase is an enzyme involved in the dismutation of the superoxide radical. Its activity 396 
has been reported to be 36 U/mL in term mature breast milk [140]. Although there is a paucity of 397 
research in this area, superoxide dismutase activity was reported to be significantly reduced after 398 
preterm breast milk was stored at -20°C for seven and 30 days [135]. Glutathione content of mature 399 
breast milk is approximately 163.9 µmol/L [130]. A significant 79% loss of glutathione was noted 400 
after two hours storage at 4°C as well as at -20°C (-81% vs baseline) [130]. Glutathione peroxidase 401 
activity in mature term breast milk was reported as 38.8 U/mL [141]. Significant reductions in 402 
activity were seen in term milk after 48 hours at 4°C [110], although these were not reported 403 
following storage of preterm breast milk for 30 days at -20°C [135]. Activity decreases were reported 404 
with increased storage time at -20°C, with activity completely lost after one week [141], and 405 
significant reductions in activity after 15, 30 and 60 days in another study [116]. However, significant 406 
reductions were only shown after 60 days at -80°C, where the activity was not significantly different 407 
between the -20°C and -80°C conditions. 408 
 409 
7.4 Total antioxidant capacity 410 
Total antioxidant capacity (TAC) measures the additive effects of antioxidants and may provide a 411 
more useful measure than the assessment of individual antioxidants [142]. However, the different 412 
analytical methods for TAC have a weak or no correlations [143], making it difficult to compare 413 
results between studies. Significant reductions in the TAC of preterm and term breast milk have 414 
been reported after storage at 4°C for 48 [144], and 72 hours [145], although, others have shown 415 
that storing pooled preterm breast milk at 6.8°C for up to 96 hours not affect TAC [51]. Freezing 416 
breast milk at -20°C shows significantly reduced antioxidant capacity after 48 hours, which further 417 
decreased after one week [146], and a significant decrease after one week with further decrease 418 
after one month [147], with similar effects seen at -8°C [144]. However, others report no changes in 419 
TAC after storing preterm milk for 30 days at -20°C [135], or storing DHM at -20°C for two months 420 
[80]. Preterm colostrum stored for up to three months at -80°C did not show any change in TAC 421 
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[148], whereas term mature breast milk stored at -80°C showed significantly lower TAC after two 422 
months [149]. Thawing breast milk at 4°C for 24 hours (as recommended by the U.K. guideline [15]), 423 
as well as thawing at room temperature for 2.5 to 4.25 hours did not change TAC [85], whereas using 424 
a water-bath for thawing (50°C, 12 to 30 minutes) resulted in a significant decrease in TAC. Overall, 425 
the evidence of different storage conditions on TAC is equivocal, potentially due to differences in 426 
analytical techniques, or it may be an indicator of potential variations in the antioxidant 427 
requirements of the different samples. 428 
 429 
8. CONCLUSION AND RECOMMENDATIONS 430 
Current human milk banking practices have been developed to provide microbiological safe DHM, 431 
with limited emphasis on the nutritional quality of DHM. There are currently no globally accepted 432 
guidelines for human milk banking practices, with wide variations in practices, regulations, and 433 
organization in each country, in part due to a lack of robust evidence [22]. However, more 434 
consideration must be given to the nutritional quality of DHM to ensure optimum nutritional intake 435 
for the infants. Specific focus should be given to components such as LCPUFAs, bioactive lipid 436 
mediators, and their supporting antioxidants, as their levels are essential for the health and 437 
development of preterm infants. The literature reviewed within this article clearly demonstrates that 438 
the quality of DHM can be influenced by the various storage and processing conditions used in 439 
human milk banking. The observations of minimal changes in fat composition are consistent with a 440 
recent systematic review [25]; however, levels of lipid peroxidation products, and endogenous 441 
antioxidants appear more sensitive to the storage conditions, and when considering the effects of 442 
human milking banking practices on overall DHM lipid nutritional quality these aspects should also 443 
be considered, although further research is needed to understand these effects. 444 
Due to the diversity of methodological approaches, and biological variability of the human breast 445 
milk samples, there remain many uncertainties and a general lack of consistency in the current 446 
literature around the optimal DHM storage conditions. Indeed, this is even more apparent when 447 
considering a range of different nutritional components, where there are different sensitivities to 448 
the storage conditions and processing. It is clear that further research is needed to improve the 449 
evidence base for human milk banking practices, particularly on the effects of storage conditions on 450 
bioactive compounds such as eicosanoids, SPMs and the TAC of DHM. However, in the interim, in 451 
order to maximise the LCPUFA content, and to ensure maintenance of supporting antioxidants we 452 
must accept a certain degree of uncertainty and adopt a precautionary approach. Therefore we 453 
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suggest considering the following recommendations where possible, to supplement current local 454 
and national guidelines: 455 
 Breast milk containers should protect the milk from exposure to light, either through the use 456 
of amber containers, or if unavailable, other approaches should be put in place, such as 457 
wrapping containers in aluminium foil, and putting covers over fridges and freezers with 458 
glass doors. 459 
 DHM should be frozen at -20°C directly after expression, instead of pooling over 24 hours in 460 
the fridge. 461 
 Storage at 4°C at the human milk bank should be minimized wherever possible, and every 462 
effort should be made to transport DHM to the human milk bank as soon as possible after 463 
expression. 464 
 At the human milk bank the DHM should ideally be frozen at -70°C or below, particularly 465 
prior to pasteurisation, although more research is needed to explore the effects of long-term 466 
storage of post-pasteurised DHM. 467 
 Using different thawing methods (at room temperature, in the fridge or using a water-bath), 468 
affects breast milk components differently, and currently, the evidence suggests that 469 
thawing at 4°C is not detrimental to the fat content or TAC of the DHM.  470 
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